Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_Cancer_Germline_Mut	i_CGC_Cancer_Molecular_Genetics	i_CGC_Cancer_Somatic_Mut	i_CGC_Cancer_Syndrome	i_CGC_Chr	i_CGC_Chr_Band	i_CGC_GeneID	i_CGC_Name	i_CGC_Other_Germline_Mut	i_CGC_Tissue_Type	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_Ensembl_Gene_ID	i_HGNC_HGNC_ID	i_HGNC_RefSeq_IDs	i_HGNC_Status	i_HGNC_UCSC_ID_supplied_by_UCSC_	i_HGVS_coding_DNA_change	i_HGVS_genomic_change	i_HGVS_protein_change	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERPplusplus_NR	i_dbNSFP_GERPplusplus_RS	i_dbNSFP_GERPplusplus_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_fold_degenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos_1_coor_	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	i_picard_oxoQ	i_t_ALT_F1R2	i_t_ALT_F2R1	i_t_REF_F1R2	i_t_REF_F2R1	i_t_Foxog	pox	qox	pox_cutoff	isArtifactMode	oxoGCut	i_ffpe_Q	i_ffpe_F	i_ffpe_mode	i_ffpe_p_value	i_ffpe_q_value	i_ffpe_p_value_cutoff	i_ffpe_cut	pon_total_counts_coverage_less_8	pon_total_counts_coverage_greater_8	pon_alt_count_greater1_af_greater_01percent	pon_alt_count_greater2_af_greater_03percent	pon_alt_count_greater3_af_greater_1percent	pon_alt_count_greater3_af_greater_3percent	pon_alt_count_greater3_af_greater_20percent	pon_alt_count_greater10_af_greater_20percent	pon_loglike	pon_weight	pon_pass_grid	pon_pass_loglike	pon_pass_weight	pon_coding	pon_low_alt_count
ZIM3	0	broad.mit.edu	37	19	57649928	57649928	+	Silent	SNP	G	G	A			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr19:57649928G>A	ENST00000269834.1	-	3	439	c.54C>T	c.(52-54)acC>acT	p.T18T		NM_052882.1	NP_443114.1	Q96PE6	ZIM3_HUMAN	zinc finger, imprinted 3	18	KRAB.				regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			breast(1)|endometrium(3)|kidney(2)|large_intestine(13)|lung(27)|pancreas(1)|prostate(3)|skin(1)|urinary_tract(1)	52		Colorectal(82;0.000256)|all_neural(62;0.0577)|Ovarian(87;0.243)		UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.026)		ACTCCCCCTGGGTGAAGTTCA	0.502																																														0													99	89	93					19																	57649928		2203	4300	6503	SO:0001819	synonymous_variant				HGNC:16366		Approved	uc002qnz.1	ENST00000269834.1:c.54C>T	19.37:g.57649928G>A			Q14CA6	ENST00000269834.1	37	CCDS33125.1																																																																																			ZIM3-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000465078.1	2.070947	KEEP		-	8.211674	0.102564	4	35					36.76	4	0	27	18	1.0	0.0	0.0	1	0	0	29.76	0.0	1	2.56e-06	4.12444e-06	0.150653	0	44	8018	156	86	21	9	0	0	-2.996739	0.9866961	1	1	1	1	0
SNX9	51429	broad.mit.edu	37	6	158327188	158327188	+	Missense_Mutation	SNP	G	G	A			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr6:158327188G>A	ENST00000392185.3	+	7	820	c.649G>A	c.(649-651)Gaa>Aaa	p.E217K		NM_016224.3	NP_057308.1	Q9Y5X1	SNX9_HUMAN	sorting nexin 9	217					cell communication|intracellular protein transport|lipid tube assembly|positive regulation of GTPase activity|positive regulation of protein oligomerization|receptor-mediated endocytosis	clathrin-coated vesicle|cytoplasmic vesicle membrane|extrinsic to internal side of plasma membrane|ruffle|trans-Golgi network	1-phosphatidylinositol binding|protein homodimerization activity|ubiquitin protein ligase binding			central_nervous_system(1)|endometrium(3)|kidney(1)|large_intestine(3)|lung(10)|skin(1)|upper_aerodigestive_tract(1)	20		Breast(66;0.000776)|Ovarian(120;0.0303)|Prostate(117;0.167)		OV - Ovarian serous cystadenocarcinoma(65;8.06e-18)|BRCA - Breast invasive adenocarcinoma(81;4.48e-05)		ACCTGGCACGGAACAGTATTT	0.338																																														0													112	110	111					6																	158327188		2203	4300	6503	SO:0001583	missense			ENSG00000130340	HGNC:14973		Approved	uc003qqv.1	ENST00000392185.3:c.649G>A	6.37:g.158327188G>A	ENSP00000376024:p.Glu217Lys		Q9BSI7|Q9BVM1|Q9UJH6|Q9UP20	ENST00000392185.3	37	CCDS5253.1	.	.	.	.	.	.	.	.	.	.	G	25.9	4.685755	0.88639	.	.	ENSG00000130340	ENST00000539592;ENST00000392185;ENST00000252631	T	0.64803	-0.12	5.66	5.66	0.87406	.	0.052454	0.85682	D	0.000000	T	0.45256	0.1333	L	0.41492	1.28	0.80722	D	1	P	0.50819	0.939	B	0.38803	0.282	T	0.56956	-0.7893	10	0.87932	D	0	-22.4463	19.7378	0.96214	0.0:0.0:1.0:0.0	.	217	Q9Y5X1	SNX9_HUMAN	K	217;217;17	ENSP00000376024:E217K	ENSP00000252631:E17K	E	+	1	0	SNX9	158247176	1.000000	0.71417	1.000000	0.80357	0.992000	0.81027	7.720000	0.84759	2.154000	0.67381	0.533000	0.62120	GAA	SNX9-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000042856.1	-2.945823	KEEP		+	16.081555	0.076923	8	96					36.76	8	5	63	66	0.615385	0.0	0.0	1	0	0	29.76	0.384615	1	7.03913e-09	1.85577e-08	0.09319	0	50	7980	225	68	0	8	0	0	-3.01988	0.996177	1	1	1	1	0
GRM7	2917	broad.mit.edu	37	3	7494336	7494336	+	Missense_Mutation	SNP	G	G	A			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr3:7494336G>A	ENST00000486284.1	+	6	1491	c.1217G>A	c.(1216-1218)gGt>gAt	p.G406D	GRM7_ENST00000389336.4_Missense_Mutation_p.G406D|GRM7_ENST00000403881.1_Missense_Mutation_p.G406D|GRM7_ENST00000458641.2_3'UTR|GRM7_ENST00000357716.4_Missense_Mutation_p.G406D|GRM7_ENST00000402647.2_Missense_Mutation_p.G406D	NM_181874.2	NP_870989.1	Q14831	GRM7_HUMAN	glutamate receptor, metabotropic 7	406					negative regulation of adenylate cyclase activity|negative regulation of cAMP biosynthetic process|negative regulation of glutamate secretion|sensory perception of smell|sensory perception of sound|synaptic transmission	asymmetric synapse|axon|cell cortex|dendritic shaft|integral to plasma membrane|postsynaptic membrane|presynaptic active zone	adenylate cyclase inhibitor activity|calcium ion binding|glutamate binding|group III metabotropic glutamate receptor activity|PDZ domain binding|serine binding			breast(2)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(14)|lung(35)|ovary(4)|prostate(2)|skin(6)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(2)	76					L-Glutamic Acid(DB00142)	GAGCAGGAGGGTAAAGTCCAG	0.478																																														0													129	111	117					3																	7494336		2203	4300	6503	SO:0001583	missense			ENSG00000196277	HGNC:4599	NM_000844	Approved	uc003bql.2	ENST00000486284.1:c.1217G>A	3.37:g.7494336G>A	ENSP00000417536:p.Gly406Asp		Q8NFS2|Q8NFS3|Q8NFS4	ENST00000486284.1	37		.	.	.	.	.	.	.	.	.	.	G	15.93	2.977793	0.53720	.	.	ENSG00000196277	ENST00000357716;ENST00000486284;ENST00000389336;ENST00000403881;ENST00000525747;ENST00000402647;ENST00000413492;ENST00000445087	D;D;D;D;D;D	0.83075	-1.68;-1.68;-1.68;-1.68;-1.68;-1.68	5.88	5.88	0.94601	Extracellular ligand-binding receptor (1);	0.052848	0.85682	D	0.000000	T	0.82167	0.4978	L	0.60455	1.87	0.58432	D	0.999998	P;P;B	0.40360	0.666;0.714;0.292	B;P;B	0.46362	0.38;0.514;0.099	T	0.76870	-0.2799	10	0.13853	T	0.58	.	12.1645	0.54123	0.078:0.0:0.922:0.0	.	406;406;406	Q14831-5;Q14831;Q14831-2	.;GRM7_HUMAN;.	D	406;406;406;406;406;406;406;63	ENSP00000350348:G406D;ENSP00000417536:G406D;ENSP00000373987:G406D;ENSP00000385664:G406D;ENSP00000384585:G406D;ENSP00000395035:G63D	ENSP00000350348:G406D	G	+	2	0	GRM7	7469336	1.000000	0.71417	0.997000	0.53966	0.943000	0.58893	8.061000	0.89467	2.782000	0.95742	0.655000	0.94253	GGT	GRM7-015	PUTATIVE	not_organism_supported|basic	protein_coding		protein_coding	OTTHUMT00000354360.1	3.350019	KEEP		+	8.371777	0.131579	5	33					36.76	5	0	19	19	1.0	0.0	0.0	1	0	0	29.76	0.0	1	1.024e-07	2.1997e-07	0.184627	0	48	7973	244	60	7	0	0	0	-6.069305	0.9998513	1	1	1	1	0
CRIPAK	285464	broad.mit.edu	37	4	1388904	1388904	+	Missense_Mutation	SNP	C	C	T	rs71299249|rs148639884	byFrequency	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr4:1388904C>T	ENST00000324803.4	+	1	3565	c.605C>T	c.(604-606)aCg>aTg	p.T202M		NM_175918.3	NP_787114.2	Q8N1N5	CRPAK_HUMAN	cysteine-rich PAK1 inhibitor	202					ER-nucleus signaling pathway|negative regulation of protein kinase activity|regulation of cytoskeleton organization|response to estrogen stimulus	endoplasmic reticulum|nucleus|plasma membrane	protein binding			NS(3)|breast(1)|central_nervous_system(1)|endometrium(1)|kidney(2)|large_intestine(2)|lung(11)|ovary(1)|pancreas(2)|prostate(6)|skin(4)|urinary_tract(1)	35			OV - Ovarian serous cystadenocarcinoma(23;0.0106)			CCTGCTCACACGTGCCGATGT	0.657													t	23.0	0.01	0.03	0.01	2184.0		0.978	,	,		0.0026	0.01			0.0189	0.5843	LOWCOV			0.0026	SNP												0								T	MET/THR	51,4289		7,37,2126	261	176	207		605.0	0.8	0.0	4	dbSNP_134	207.0	6,7666		0,6,3830	no	missense	CRIPAK	NM_175918.3	81.0	7,43,5956	TT,TC,CC		0.0782,1.1751,0.4745	probably-damaging	202/447	1388904	57,11955	2170	3836	6006	SO:0001583	missense			ENSG00000179979	HGNC:26619	NM_175918	Approved	uc003gdf.2	ENST00000324803.4:c.605C>T	4.37:g.1388904C>T	ENSP00000323978:p.Thr202Met		Q8NB03	ENST00000324803.4	37	CCDS3349.1	23	0.010531135531135532	14	0.028455284552845527	2	0.0055248618784530384	0	0.0	7	0.009234828496042216	t	4.645	0.119885	0.08881	0.011751	7.82E-4	ENSG00000179979	ENST00000324803	T	0.20738	2.05	0.83	0.83	0.18854	Post-SET domain (1);	.	.	.	.	T	0.01905	0.0060	N	0.08118	0	0.09310	N	1	P	0.44734	0.842	B	0.26614	0.071	T	0.25641	-1.0126	9	0.66056	D	0.02	.	3.2139	0.06692	0.0:0.6945:0.0:0.3055	.	202	Q8N1N5	CRPAK_HUMAN	M	202	ENSP00000323978:T202M	ENSP00000323978:T202M	T	+	2	0	CRIPAK	1378904	0.007000	0.16637	0.003000	0.11579	0.025000	0.11179	0.234000	0.17930	0.770000	0.33336	0.413000	0.27773	ACG	CRIPAK-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000241607.2	-0.624164	KEEP		+	7.57513	0.085106	4	43					36.76	0	4	33	25	1.0	0.0	0.0	1	0	0	29.76	0.0	1	2.56e-06	4.12444e-06	0.150653	0	949	7069	226	52	20	0	4	14	-4.05609	0.0318582	0	1	0	1	0
SIK2	23235	broad.mit.edu	37	11	111591679	111591679	+	Nonsense_Mutation	SNP	G	G	T			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr11:111591679G>T	ENST00000304987.3	+	12	2010	c.1837G>T	c.(1837-1839)Gag>Tag	p.E613*		NM_015191.1	NP_056006.1	Q9H0K1	SIK2_HUMAN	salt-inducible kinase 2	613					intracellular protein kinase cascade|regulation of insulin receptor signaling pathway	Golgi apparatus	ATP binding|magnesium ion binding|protein binding|protein serine/threonine kinase activity			breast(1)|central_nervous_system(2)|cervix(2)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(5)|lung(7)|prostate(3)|skin(1)|upper_aerodigestive_tract(3)	30						AGGAATTCTAGAGTTGAACAA	0.458																																														0													106	108	107					11																	111591679		2201	4297	6498	SO:0001587	stop_gained			ENSG00000170145	HGNC:21680	NM_015191	Approved	uc001plt.3	ENST00000304987.3:c.1837G>T	11.37:g.111591679G>T	ENSP00000305976:p.Glu613*		B0YJ94|O94878|Q17RV0|Q6AZE2|Q76N03|Q8NCV7|Q96CZ8	ENST00000304987.3	37	CCDS8347.1	.	.	.	.	.	.	.	.	.	.	G	40	8.179046	0.98691	.	.	ENSG00000170145	ENST00000304987	.	.	.	6.17	6.17	0.99709	.	0.047369	0.85682	D	0.000000	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.34782	T	0.22	.	20.4898	0.99202	0.0:0.0:1.0:0.0	.	.	.	.	X	613	.	ENSP00000305976:E613X	E	+	1	0	SIK2	111096889	1.000000	0.71417	0.999000	0.59377	0.994000	0.84299	9.357000	0.97099	2.941000	0.99782	0.655000	0.94253	GAG	SIK2-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000319352.3	16.215006	KEEP		+	27.405484	0.142857	13	78					36.76	9	8	47	53	0.529412	1.15088e-07	1.28367e-07	1	1	0	29.76	0.470588	0	0.0	0.0	0.146539	0	47	8085	124	63	10	5	0	0	-3.266314	0.9996569	1	1	1	1	0
TNFAIP1	7126	broad.mit.edu	37	17	26671454	26671454	+	Missense_Mutation	SNP	G	G	A			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr17:26671454G>A	ENST00000226225.2	+	7	1046	c.779G>A	c.(778-780)cGc>cAc	p.R260H	TNFAIP1_ENST00000583213.1_3'UTR|TNFAIP1_ENST00000544907.2_Missense_Mutation_p.R156H	NM_021137.4	NP_066960.1	Q13829	BACD2_HUMAN	tumor necrosis factor, alpha-induced protein 1 (endothelial)	260					apoptosis|cell migration|DNA replication|embryo development|immune response|negative regulation of Rho protein signal transduction|proteasomal ubiquitin-dependent protein catabolic process|protein ubiquitination|stress fiber assembly	Cul3-RING ubiquitin ligase complex|endosome|nucleus|voltage-gated potassium channel complex	GTP-Rho binding|voltage-gated potassium channel activity			endometrium(3)|kidney(1)|large_intestine(4)|lung(3)|prostate(1)	12	all_lung(13;0.000294)|Lung NSC(42;0.000964)			UCEC - Uterine corpus endometrioid carcinoma (53;0.153)		GAGACTCCCCGCGTCCCCGAC	0.587																																														0													55	48	50					17																	26671454		2203	4300	6503	SO:0001583	missense			ENSG00000109079	HGNC:11894	NM_021137	Approved	uc002hay.3	ENST00000226225.2:c.779G>A	17.37:g.26671454G>A	ENSP00000226225:p.Arg260His		Q5TZQ1	ENST00000226225.2	37	CCDS11227.1	.	.	.	.	.	.	.	.	.	.	G	26.3	4.720036	0.89205	.	.	ENSG00000109079	ENST00000226225;ENST00000544907	T	0.55234	0.53	5.65	4.66	0.58398	.	0.131291	0.52532	D	0.000068	T	0.58104	0.2099	M	0.66939	2.045	0.51012	D	0.999902	D	0.54397	0.966	P	0.47044	0.535	T	0.63229	-0.6684	10	0.48119	T	0.1	-8.2606	15.6339	0.76933	0.0:0.1375:0.8625:0.0	.	260	Q13829	BACD2_HUMAN	H	260;156	ENSP00000226225:R260H	ENSP00000226225:R260H	R	+	2	0	TNFAIP1	23695581	0.992000	0.36948	0.921000	0.36526	0.944000	0.59088	5.522000	0.67092	1.585000	0.49928	0.655000	0.94253	CGC	TNFAIP1-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000255681.2	16.292636	KEEP		+	18.10732	0.25	8	24					36.76	6	2	13	15	0.75	0.0	0.0	1	0	0	29.76	0.25	1	1.06961e-07	2.21563e-07	0.038147	0	120	7668	488	53	0	4	0	0	-4.017685	0.9989194	1	1	1	1	0
SLC4A4	8671	broad.mit.edu	37	4	72423438	72423438	+	Missense_Mutation	SNP	C	C	T			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr4:72423438C>T	ENST00000340595.3	+	19	2837	c.2641C>T	c.(2641-2643)Cgt>Tgt	p.R881C	SLC4A4_ENST00000264485.5_Missense_Mutation_p.R925C|SLC4A4_ENST00000425175.1_Missense_Mutation_p.R925C|SLC4A4_ENST00000351898.6_Missense_Mutation_p.R841C	NM_003759.3	NP_003750.1	Q9Y6R1	S4A4_HUMAN	solute carrier family 4 (sodium bicarbonate cotransporter), member 4	925						basolateral plasma membrane|integral to plasma membrane	inorganic anion exchanger activity|protein binding|sodium:bicarbonate symporter activity			breast(3)|central_nervous_system(1)|cervix(1)|endometrium(6)|kidney(2)|large_intestine(9)|liver(1)|lung(21)|ovary(3)|pancreas(1)|prostate(1)|skin(6)|upper_aerodigestive_tract(2)|urinary_tract(1)	58			Lung(101;0.0739)|LUSC - Lung squamous cell carcinoma(112;0.225)			GTTCATGGATCGTCTGAAGCT	0.453																																														0			GRCh37	CM056990	SLC4A4	M							119	102	107					4																	72423438		2203	4300	6503	SO:0001583	missense			ENSG00000080493	HGNC:11030	NM_003759	Approved	uc010iic.3	ENST00000340595.3:c.2641C>T	4.37:g.72423438C>T	ENSP00000344272:p.Arg881Cys		C4B714|O15153|Q8NEJ2|Q9H262|Q9NRZ1|Q9UIC0|Q9UIC1|Q9UP50	ENST00000340595.3	37	CCDS3549.1	.	.	.	.	.	.	.	.	.	.	C	33	5.240856	0.95272	.	.	ENSG00000080493	ENST00000264485;ENST00000425175;ENST00000351898;ENST00000340595	D;D;D;D	0.86694	-2.16;-2.16;-1.59;-2.16	5.95	5.95	0.96441	Bicarbonate transporter, C-terminal (1);	0.000000	0.85682	D	0.000000	D	0.96125	0.8737	H	0.96430	3.82	0.80722	D	1	D;D;D;D	0.89917	1.0;1.0;1.0;1.0	D;D;D;D	0.97110	1.0;0.975;1.0;1.0	D	0.96634	0.9469	10	0.87932	D	0	.	20.3789	0.98926	0.0:1.0:0.0:0.0	.	925;841;881;925	A5JJ20;Q9Y6R1-4;Q9Y6R1-2;Q9Y6R1	.;.;.;S4A4_HUMAN	C	925;925;841;881	ENSP00000264485:R925C;ENSP00000393557:R925C;ENSP00000307349:R841C;ENSP00000344272:R881C	ENSP00000264485:R925C	R	+	1	0	SLC4A4	72642302	1.000000	0.71417	1.000000	0.80357	0.979000	0.70002	7.818000	0.86416	2.826000	0.97356	0.563000	0.77884	CGT	SLC4A4-001	KNOWN	basic|CCDS	protein_coding		protein_coding	OTTHUMT00000252158.2	7.926965	KEEP		+	11.946666	0.162162	6	31					36.76	4	2	19	19	0.333333	0.0	0.0	1	0	0	29.76	0.666667	1	0.0215528	0.0277791	0.021553	0	55	7975	224	69	8	0	0	0	-6.932538	0.99987	1	1	1	1	0
ZMYM5	9205	broad.mit.edu	37	13	20409679	20409679	+	Silent	SNP	G	G	A			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr13:20409679G>A	ENST00000337963.4	-	7	1453	c.1189C>T	c.(1189-1191)Ctg>Ttg	p.L397L		NM_001142684.1	NP_001136156.1	Q9UJ78	ZMYM5_HUMAN	zinc finger, MYM-type 5	397						nucleus	zinc ion binding			kidney(1)|large_intestine(5)|lung(9)	15		all_cancers(29;2.96e-22)|all_epithelial(30;3.76e-20)|all_lung(29;4.38e-20)|Lung NSC(5;5.8e-17)|Lung SC(185;0.0262)|Ovarian(182;0.162)		all cancers(112;1.61e-05)|Epithelial(112;4.89e-05)|OV - Ovarian serous cystadenocarcinoma(117;0.00171)|Lung(94;0.00942)|LUSC - Lung squamous cell carcinoma(192;0.0431)		CCAATCACCAGGATGTTGTTT	0.363																																														0													104	88	93					13																	20409679		1568	3582	5150	SO:0001819	synonymous_variant			ENSG00000132950	HGNC:13029	NM_014242	Approved	uc010tcn.1	ENST00000337963.4:c.1189C>T	13.37:g.20409679G>A			B2R6V1|Q5T6E1|Q5T6E2|Q5T6E4|Q96IY6|Q9NZY5|Q9UBW0|Q9UJ77	ENST00000337963.4	37																																																																																				ZMYM5-201	KNOWN	basic|appris_principal	protein_coding		protein_coding		16.648355	KEEP		-	20.418173	0.2	9	36					36.76	4	5	18	23	0.444444	0.0	0.0	1	0	0	29.76	0.555556	1	0.000274275	0.000378761	0.047766	0	92	7908	259	59	5	11	0	0	-3.234538	0.9976573	1	1	1	1	0
PTCHD3	374308	broad.mit.edu	37	10	27687638	27687638	+	Missense_Mutation	SNP	C	C	T	rs142594066	byFrequency	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr10:27687638C>T	ENST00000438700.3	-	4	2006	c.1889G>A	c.(1888-1890)cGa>cAa	p.R630Q		NM_001034842.3	NP_001030014.2	Q3KNS1	PTHD3_HUMAN	patched domain containing 3	630					spermatid development	integral to membrane	hedgehog receptor activity			NS(1)|breast(2)|central_nervous_system(1)|cervix(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(12)|lung(17)|ovary(3)|pancreas(1)|prostate(1)|skin(3)|upper_aerodigestive_tract(3)	55						TGCCAGATTTCGAAGGTCTAA	0.358																																														0								C	GLN/ARG	6,4400	11.4+/-27.6	0,6,2197	77	77	77		1889.0	2.3	0.6	10	dbSNP_134	77.0	23,8577	17.9+/-57.8	0,23,4277	yes	missense	PTCHD3	NM_001034842.3	43.0	0,29,6474	TT,TC,CC		0.2674,0.1362,0.223	possibly-damaging	630/768	27687638	29,12977	2203	4300	6503	SO:0001583	missense			ENSG00000182077	HGNC:24776	XM_370541	Approved	uc001itu.2	ENST00000438700.3:c.1889G>A	10.37:g.27687638C>T	ENSP00000417658:p.Arg630Gln		Q6ZU28	ENST00000438700.3	37	CCDS31173.1	.	.	.	.	.	.	.	.	.	.	C	14.69	2.609709	0.46527	0.001362	0.002674	ENSG00000182077	ENST00000438700	D	0.85171	-1.95	4.19	2.27	0.28462	.	0.525534	0.18522	N	0.138750	T	0.75975	0.3923	L	0.38531	1.155	0.24486	N	0.994326	B	0.26445	0.149	B	0.34824	0.19	T	0.59193	-0.7500	10	0.14252	T	0.57	-4.7404	5.6862	0.17805	0.0:0.6582:0.1627:0.1791	.	630	Q3KNS1	PTHD3_HUMAN	Q	630	ENSP00000417658:R630Q	ENSP00000417658:R630Q	R	-	2	0	PTCHD3	27727644	1.000000	0.71417	0.625000	0.29200	0.992000	0.81027	2.045000	0.41250	0.391000	0.25143	0.484000	0.47621	CGA	PTCHD3-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000047325.3	0.166324	KEEP		-	7.593651	0.090909	4	40					36.76	3	3	22	29	0.5	0.0	0.0	1	0	0	29.76	0.5	1	0.00116845	0.00157604	0.021553	0	49	7860	255	80	9	6	0	75	-2.982776	0.0	0	1	0	1	0
NPEPPS	9520	broad.mit.edu	37	17	45669405	45669405	+	Silent	SNP	G	G	C			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr17:45669405G>C	ENST00000322157.4	+	11	1581	c.1344G>C	c.(1342-1344)ctG>ctC	p.L448L	NPEPPS_ENST00000544660.1_Silent_p.L368L|NPEPPS_ENST00000530173.1_Silent_p.L444L|NPEPPS_ENST00000525037.1_3'UTR	NM_006310.3	NP_006301.3	P55786	PSA_HUMAN	aminopeptidase puromycin sensitive	448					proteolysis	cytosol|nucleus	aminopeptidase activity|metallopeptidase activity|protein binding|zinc ion binding			breast(1)|central_nervous_system(1)|endometrium(7)|kidney(1)|large_intestine(6)|lung(7)|prostate(2)|skin(1)|upper_aerodigestive_tract(1)	27						TCCGAATGCTGCATGACTACA	0.358																																														0													131	76	94					17																	45669405		1919	4100	6019	SO:0001819	synonymous_variant			ENSG00000141279	HGNC:7900	NM_006310	Approved	uc002ilr.4	ENST00000322157.4:c.1344G>C	17.37:g.45669405G>C			Q6P145|Q9NP16|Q9UEM2	ENST00000322157.4	37	CCDS45721.1																																																																																			NPEPPS-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000384269.1	4.409431	KEEP		+	7.464714	0.130435	3	20					36.76	3	0	13	17	1.0	0.0	0.0	1	0	0	29.76	0.0	0	0.0	0.0	0.115264	0	95	7765	403	56	13	0	0	0	-5.08067	0.9980392	1	1	1	1	0
SEC24D	9871	broad.mit.edu	37	4	119689386	119689386	+	Missense_Mutation	SNP	C	C	T			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr4:119689386C>T	ENST00000379735.5	-	9	1396	c.1125G>A	c.(1123-1125)atG>atA	p.M375I	SEC24D_ENST00000419654.2_5'UTR|SEC24D_ENST00000280551.6_Missense_Mutation_p.M374I|SEC24D_ENST00000511481.1_Missense_Mutation_p.M5I	NM_014822.2	NP_055637.2	O94855	SC24D_HUMAN	SEC24 family member D	374	Zinc finger-like.				COPII vesicle coating|intracellular protein transport|post-translational protein modification|protein N-linked glycosylation via asparagine	COPII vesicle coat|cytosol|endoplasmic reticulum membrane|Golgi membrane|perinuclear region of cytoplasm	zinc ion binding			breast(3)|cervix(1)|endometrium(5)|kidney(1)|large_intestine(10)|lung(13)|prostate(1)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)	37						CGATGAACTGCATAAATGGGC	0.428																																														0													132	116	121					4																	119689386		2203	4300	6503	SO:0001583	missense			ENSG00000150961	HGNC:10706		Approved	uc003ici.4	ENST00000379735.5:c.1125G>A	4.37:g.119689386C>T	ENSP00000369059:p.Met375Ile		Q8IYI7	ENST00000379735.5	37		.	.	.	.	.	.	.	.	.	.	C	34	5.363203	0.95877	.	.	ENSG00000150961	ENST00000280551;ENST00000379735;ENST00000511481	T;T;T	0.76186	1.98;1.98;-1.0	5.96	5.96	0.96718	Zinc finger, Sec23/Sec24-type (1);	0.000000	0.85682	D	0.000000	D	0.85137	0.5628	M	0.63428	1.95	0.80722	D	1	P;D	0.58970	0.919;0.984	P;D	0.65443	0.894;0.935	D	0.85210	0.1020	10	0.87932	D	0	-17.4395	20.4014	0.98996	0.0:1.0:0.0:0.0	.	375;374	O94855-2;O94855	.;SC24D_HUMAN	I	374;375;5	ENSP00000280551:M374I;ENSP00000369059:M375I;ENSP00000425491:M5I	ENSP00000280551:M374I	M	-	3	0	SEC24D	119908834	1.000000	0.71417	1.000000	0.80357	0.918000	0.54935	7.772000	0.85439	2.819000	0.97034	0.585000	0.79938	ATG	SEC24D-201	KNOWN	basic|appris_candidate_longest	protein_coding		protein_coding		-10.395106	KEEP		-	7.496209	0.057471	5	82					36.76	0	5	58	35	1.0	0.0	0.0	1	0	0	29.76	0.0	1	1.024e-07	2.1997e-07	0.184627	0	48	8061	183	33	6	0	0	0	-4.449855	0.999967	1	1	1	1	0
ADAP2	55803	broad.mit.edu	37	17	29258984	29258984	+	Missense_Mutation	SNP	C	C	A			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr17:29258984C>A	ENST00000330889.3	+	4	730	c.395C>A	c.(394-396)cCa>cAa	p.P132Q	ADAP2_ENST00000580525.1_Missense_Mutation_p.P138Q	NM_018404.2	NP_060874.1	Q9NPF8	ADAP2_HUMAN	ArfGAP with dual PH domains 2	132	PH 1.				heart development|regulation of ARF GTPase activity	mitochondrial envelope|plasma membrane	ARF GTPase activator activity|inositol 1,3,4,5 tetrakisphosphate binding|phosphatidylinositol-3,4,5-trisphosphate binding|phosphatidylinositol-3,4-bisphosphate binding|phosphatidylinositol-4,5-bisphosphate binding|protein binding, bridging|zinc ion binding	p.?(1)		breast(1)|endometrium(1)|large_intestine(3)|lung(5)|ovary(1)|prostate(1)|skin(1)	13						ATCTCGCTCCCAGGTAAAGTT	0.413																																														1	Unknown(1)	central_nervous_system(1)											93	93	93					17																	29258984		2203	4300	6503	SO:0001583	missense			ENSG00000184060	HGNC:16487	NM_018404	Approved	uc002hfx.3	ENST00000330889.3:c.395C>A	17.37:g.29258984C>A	ENSP00000329468:p.Pro132Gln		Q8N4Q6|Q96SD5	ENST00000330889.3	37	CCDS11261.1	.	.	.	.	.	.	.	.	.	.	C	13.64	2.296353	0.40594	.	.	ENSG00000184060	ENST00000330889	T	0.24538	1.85	5.83	5.83	0.93111	Pleckstrin homology domain (1);	0.519174	0.23389	N	0.048705	T	0.16727	0.0402	N	0.08118	0	0.42308	D	0.992204	P;B;B	0.51240	0.943;0.206;0.014	P;B;B	0.45037	0.467;0.133;0.011	T	0.09378	-1.0677	10	0.18276	T	0.48	.	15.6239	0.76833	0.0:1.0:0.0:0.0	.	138;132;132	Q2V6Q1;Q9NPF8-2;Q9NPF8	.;.;ADAP2_HUMAN	Q	132	ENSP00000329468:P132Q	ENSP00000329468:P132Q	P	+	2	0	ADAP2	26283110	0.999000	0.42202	0.990000	0.47175	0.765000	0.43378	4.763000	0.62257	2.764000	0.94973	0.557000	0.71058	CCA	ADAP2-001	KNOWN	basic|appris_candidate|CCDS	protein_coding		protein_coding	OTTHUMT00000256346.1	4.81347	KEEP		+	6.492253	0.176471	3	14					36.76	2	2	9	10	0.5	0.00909568	0.00942053	1	1	0	29.76	0.5	0	0.0	0.0	0.150653	0	48	7822	313	96	15	40	0	0	-2.621678	0.7788544	1	1	1	1	0
MRPS30	10884	broad.mit.edu	37	5	44812020	44812020	+	Missense_Mutation	SNP	G	G	T			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr5:44812020G>T	ENST00000507110.1	+	3	789	c.751G>T	c.(751-753)Gtg>Ttg	p.V251L		NM_016640.3	NP_057724.2	Q9NP92	RT30_HUMAN	mitochondrial ribosomal protein S30	251					apoptosis|translation	mitochondrion|ribosome	structural constituent of ribosome			central_nervous_system(1)|cervix(1)|endometrium(4)|large_intestine(2)|lung(11)|prostate(1)	20	Lung NSC(6;8.08e-07)					CTTTAAGTTTGTGCCATTGGA	0.294																																														0													63	65	65					5																	44812020		2203	4298	6501	SO:0001583	missense			ENSG00000112996	HGNC:8769	NM_016640	Approved	uc003joh.3	ENST00000507110.1:c.751G>T	5.37:g.44812020G>T	ENSP00000424328:p.Val251Leu		Q96I91|Q96Q19|Q9H0P8|Q9NSF9|Q9NZ76	ENST00000507110.1	37	CCDS3951.1	.	.	.	.	.	.	.	.	.	.	G	17.68	3.448954	0.63178	.	.	ENSG00000112996	ENST00000507110	T	0.17528	2.27	5.46	5.46	0.80206	.	0.237201	0.43579	D	0.000546	T	0.30572	0.0769	M	0.76002	2.32	0.39346	D	0.965676	P	0.48503	0.911	P	0.49752	0.621	T	0.09930	-1.0652	10	0.14656	T	0.56	-19.6152	17.4958	0.87717	0.0:0.0:1.0:0.0	.	251	Q9NP92	RT30_HUMAN	L	251	ENSP00000424328:V251L	ENSP00000424328:V251L	V	+	1	0	MRPS30	44847777	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	4.228000	0.58619	2.550000	0.86006	0.655000	0.94253	GTG	MRPS30-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000214033.2	4.977556	KEEP		+	30.821872	0.099379	16	145					36.76	8	9	96	90	0.470588	4.7546e-09	5.6279e-09	1	1	0	29.76	0.529412	0	0.0	0.0	0.146539	0	52	8067	167	45	0	0	0	0	-19.99914	0.9999971	1	1	1	1	0
TTF1	7270	broad.mit.edu	37	9	135277323	135277323	+	Missense_Mutation	SNP	C	C	T			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr9:135277323C>T	ENST00000334270.2	-	2	925	c.886G>A	c.(886-888)Gga>Aga	p.G296R		NM_001205296.1|NM_007344.3	NP_001192225.1|NP_031370.2	Q15361	TTF1_HUMAN	transcription termination factor, RNA polymerase I	296					negative regulation of DNA replication|regulation of transcription, DNA-dependent|termination of RNA polymerase I transcription	nucleolus|nucleoplasm	DNA binding			endometrium(3)|kidney(1)|large_intestine(5)|lung(13)|ovary(2)|pancreas(2)|stomach(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	30		Myeloproliferative disorder(178;0.204)		OV - Ovarian serous cystadenocarcinoma(145;4.25e-06)|Epithelial(140;9.09e-05)		ACTTGTGATCCTTCAGGCATG	0.468																																														0													157	152	153					9																	135277323		2203	4300	6503	SO:0001583	missense			ENSG00000125482	HGNC:12397	NM_007344	Approved	uc004cbl.3	ENST00000334270.2:c.886G>A	9.37:g.135277323C>T	ENSP00000333920:p.Gly296Arg		A1L160|Q4VXF3|Q58EY2|Q6P5T5	ENST00000334270.2	37	CCDS6948.1	.	.	.	.	.	.	.	.	.	.	C	0.027	-1.363604	0.01235	.	.	ENSG00000125482	ENST00000334270;ENST00000245588	T	0.11712	2.75	2.25	-1.43	0.08884	.	.	.	.	.	T	0.05686	0.0149	N	0.22421	0.69	0.09310	N	1	B	0.27791	0.189	B	0.15052	0.012	T	0.39742	-0.9599	9	0.27785	T	0.31	.	6.0643	0.19854	0.0:0.5103:0.0:0.4897	.	296	Q15361	TTF1_HUMAN	R	296	ENSP00000333920:G296R	ENSP00000245588:G296R	G	-	1	0	TTF1	134267144	0.000000	0.05858	0.000000	0.03702	0.000000	0.00434	-0.519000	0.06260	-0.400000	0.07656	-0.444000	0.05651	GGA	TTF1-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000054784.2	-29.517932	KEEP		-	10.968605	0.039548	7	170					36.76	1	6	128	95	0.857143	0.0	0.0	1	0	0	29.76	0.142857	1	2.7689e-08	6.98243e-08	0.02938	0	46	8120	45	45	75	0	0	0	-2.819959	0.9043402	1	1	1	1	0
SULT2A1	6822	broad.mit.edu	37	19	48386985	48386985	+	Nonsense_Mutation	SNP	C	C	T			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr19:48386985C>T	ENST00000222002.3	-	2	333	c.194G>A	c.(193-195)tGg>tAg	p.W65*		NM_003167.3	NP_003158.2	Q06520	ST2A1_HUMAN	sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1	65					3'-phosphoadenosine 5'-phosphosulfate metabolic process|bile acid catabolic process|cellular lipid metabolic process|digestion|sulfation|xenobiotic metabolic process	cytosol	bile-salt sulfotransferase activity			breast(2)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(2)|lung(10)|ovary(1)|pancreas(1)|skin(1)	20		all_cancers(25;3.02e-09)|all_lung(116;6.48e-07)|all_epithelial(76;7.35e-07)|Lung NSC(112;1.56e-06)|all_neural(266;0.0146)|Ovarian(192;0.0261)|Breast(70;0.203)		OV - Ovarian serous cystadenocarcinoma(262;0.000254)|all cancers(93;0.000545)|Epithelial(262;0.0217)|GBM - Glioblastoma multiforme(486;0.0552)		AGATTGGATCCACTTGGCATC	0.473																																														0													85	76	79					19																	48386985		2203	4300	6503	SO:0001587	stop_gained			ENSG00000105398	HGNC:11458	NM_003167	Approved	uc002phr.2	ENST00000222002.3:c.194G>A	19.37:g.48386985C>T	ENSP00000222002:p.Trp65*			ENST00000222002.3	37	CCDS12707.1	.	.	.	.	.	.	.	.	.	.	C	15.12	2.738104	0.49045	.	.	ENSG00000105398	ENST00000222002	.	.	.	3.39	2.31	0.28768	.	0.387780	0.21896	N	0.067505	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.02654	T	1	.	8.8881	0.35416	0.0:0.8817:0.0:0.1183	.	.	.	.	X	65	.	ENSP00000222002:W65X	W	-	2	0	SULT2A1	53078797	0.005000	0.15991	0.124000	0.21820	0.075000	0.17131	0.540000	0.23191	0.753000	0.32945	0.643000	0.83706	TGG	SULT2A1-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000369044.1	8.290076	KEEP		-	9.568351	0.222222	4	14					36.76	0	4	6	10	1.0	0.0	0.0	1	0	0	29.76	0.0	1	2.56e-06	4.12444e-06	0.150653	0	47	7989	222	64	5	7	0	0	-3.561666	0.9994644	1	1	1	1	0
APOB	338	broad.mit.edu	37	2	21235189	21235189	+	Silent	SNP	C	C	T			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr2:21235189C>T	ENST00000233242.1	-	26	4678	c.4551G>A	c.(4549-4551)gaG>gaA	p.E1517E		NM_000384.2	NP_000375	P04114	APOB_HUMAN	apolipoprotein B	1517					cholesterol homeostasis|cholesterol metabolic process|leukocyte migration|low-density lipoprotein particle clearance|low-density lipoprotein particle remodeling|platelet activation|positive regulation of cholesterol storage|positive regulation of macrophage derived foam cell differentiation|receptor-mediated endocytosis|response to virus	chylomicron remnant|clathrin-coated endocytic vesicle membrane|endoplasmic reticulum lumen|endoplasmic reticulum membrane|endosome lumen|endosome membrane|intermediate-density lipoprotein particle|low-density lipoprotein particle|mature chylomicron|microsome|plasma membrane|very-low-density lipoprotein particle	cholesterol transporter activity|enzyme binding|heparin binding|low-density lipoprotein particle receptor binding|phospholipid binding|protein heterodimerization activity			NS(5)|autonomic_ganglia(1)|breast(6)|central_nervous_system(4)|cervix(3)|endometrium(19)|kidney(10)|large_intestine(63)|liver(5)|lung(125)|ovary(16)|pancreas(1)|prostate(5)|skin(31)|stomach(1)|upper_aerodigestive_tract(4)|urinary_tract(6)	305	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)				Atorvastatin(DB01076)	TCAGGTTGGACTCTCCATTGA	0.502																																														0													131	129	130					2																	21235189		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000084674	HGNC:603		Approved	uc002red.3	ENST00000233242.1:c.4551G>A	2.37:g.21235189C>T			O00502|P78479|P78480|P78481|Q13779|Q13785|Q13786|Q13787|Q13788|Q4ZG63|Q53QC8|Q7Z600|Q9UMN0	ENST00000233242.1	37	CCDS1703.1																																																																																			APOB-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000207571.1	7.590096	KEEP		-	8.6811	0.235294	4	13					36.76	0	4	9	6	1.0	0.0	0.0	1	0	0	29.76	0.0	1	2.56e-06	4.12444e-06	0.150653	0	48	8105	163	13	5	0	0	0	-7.045679	0.9999999	1	1	1	1	0
DSCAML1	57453	broad.mit.edu	37	11	117403210	117403210	+	Missense_Mutation	SNP	C	C	T			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr11:117403210C>T	ENST00000321322.6	-	4	720	c.719G>A	c.(718-720)gGc>gAc	p.G240D	DSCAML1_ENST00000527706.1_Intron	NM_020693.2	NP_065744.2	Q8TD84	DSCL1_HUMAN	Down syndrome cell adhesion molecule like 1	180	Ig-like C2-type 3.				axonogenesis|brain development|cell fate determination|dorsal/ventral pattern formation|embryonic skeletal system morphogenesis|homophilic cell adhesion	cell surface|integral to membrane|plasma membrane	protein homodimerization activity			breast(3)|cervix(1)|endometrium(7)|haematopoietic_and_lymphoid_tissue(3)|kidney(7)|large_intestine(24)|lung(49)|ovary(6)|pancreas(1)|prostate(2)|skin(3)|stomach(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	110	all_hematologic(175;0.0487)	Breast(348;0.0424)|Medulloblastoma(222;0.0523)|all_hematologic(192;0.232)		BRCA - Breast invasive adenocarcinoma(274;9.12e-06)|Epithelial(105;0.00172)		GTACAGCCCGCCGTGGTAGGT	0.542																																														0													93	85	88					11																	117403210		2201	4296	6497	SO:0001583	missense			ENSG00000177103	HGNC:14656	NM_020693	Approved	uc001prh.1	ENST00000321322.6:c.719G>A	11.37:g.117403210C>T	ENSP00000315465:p.Gly240Asp		Q76MU9|Q8IZY3|Q8IZY4|Q8WXU7|Q9ULT7	ENST00000321322.6	37	CCDS8384.1	.	.	.	.	.	.	.	.	.	.	C	26.1	4.700248	0.88924	.	.	ENSG00000177103	ENST00000321322	D	0.81739	-1.53	4.88	4.88	0.63580	Immunoglobulin subtype (1);Immunoglobulin-like (1);Immunoglobulin-like fold (1);	.	.	.	.	D	0.91975	0.7458	M	0.91972	3.26	0.80722	D	1	D	0.89917	1.0	D	0.83275	0.996	D	0.93395	0.6755	9	0.72032	D	0.01	.	18.5819	0.91174	0.0:1.0:0.0:0.0	.	180	Q8TD84	DSCL1_HUMAN	D	240	ENSP00000315465:G240D	ENSP00000315465:G240D	G	-	2	0	DSCAML1	116908420	1.000000	0.71417	1.000000	0.80357	0.824000	0.46624	7.563000	0.82314	2.688000	0.91661	0.655000	0.94253	GGC	DSCAML1-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000392907.2	3.074693	KEEP		-	7.965052	0.117647	4	30					36.76	3	1	25	14	0.25	0.0	0.0	1	0	0	29.76	0.75	1	0.150653	0.178324	0.150653	0	47	8008	218	54	5	0	0	0	-5.650941	0.9999407	1	1	1	1	0
CNTN2	6900	broad.mit.edu	37	1	205036234	205036234	+	Missense_Mutation	SNP	G	G	T			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr1:205036234G>T	ENST00000331830.4	+	16	2265	c.1981G>T	c.(1981-1983)Gca>Tca	p.A661S		NM_005076.3	NP_005067.1	Q02246	CNTN2_HUMAN	contactin 2 (axonal)	661	Fibronectin type-III 1.				axon guidance|clustering of voltage-gated potassium channels	anchored to membrane|juxtaparanode region of axon|myelin sheath|node of Ranvier|synapse part	identical protein binding			NS(1)|breast(4)|central_nervous_system(1)|endometrium(4)|kidney(2)|large_intestine(11)|lung(23)|ovary(1)|prostate(3)|skin(3)|upper_aerodigestive_tract(1)	54	all_cancers(21;0.144)|Breast(84;0.0437)		KIRC - Kidney renal clear cell carcinoma(13;0.0584)|Kidney(21;0.0934)|BRCA - Breast invasive adenocarcinoma(75;0.158)			TGCAGATCCTGCAAACATCGA	0.572																																			Melanoma(183;2548 2817 37099 41192)											0													80	75	76					1																	205036234		2203	4300	6503	SO:0001583	missense			ENSG00000184144	HGNC:2172	NM_005076	Approved	uc001hbr.3	ENST00000331830.4:c.1981G>T	1.37:g.205036234G>T	ENSP00000330633:p.Ala661Ser		P78432|Q5T054	ENST00000331830.4	37	CCDS1449.1	.	.	.	.	.	.	.	.	.	.	G	14.01	2.409080	0.42715	.	.	ENSG00000184144	ENST00000331830	T	0.56776	0.44	5.51	4.6	0.57074	Fibronectin, type III (4);Immunoglobulin-like fold (1);	0.540328	0.15717	N	0.248104	T	0.32852	0.0843	N	0.16201	0.385	0.09310	N	0.999998	B;B	0.18610	0.029;0.029	B;B	0.22152	0.023;0.038	T	0.19811	-1.0294	10	0.13108	T	0.6	.	9.7112	0.40247	0.0751:0.1405:0.7844:0.0	.	661;552	Q02246;Q68DA2	CNTN2_HUMAN;.	S	661	ENSP00000330633:A661S	ENSP00000330633:A661S	A	+	1	0	CNTN2	203302857	0.103000	0.21917	0.989000	0.46669	0.978000	0.69477	2.261000	0.43276	1.330000	0.45394	0.467000	0.42956	GCA	CNTN2-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000090080.3	6.184297	KEEP		+	8.714576	0.166667	4	20					36.76	1	3	15	11	0.25	0.00024832	0.000266714	1	1	0	29.76	0.75	0	0.0	0.0	0.150653	0	52	7871	331	77	0	0	0	0	-9.939091	0.9997463	1	1	1	1	0
ZNF28	7576	broad.mit.edu	37	19	53304481	53304481	+	Missense_Mutation	SNP	C	C	T			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr19:53304481C>T	ENST00000438150.2	-	2	1351	c.458G>A	c.(457-459)cGg>cAg	p.R153Q	ZNF28_ENST00000457749.2_Missense_Mutation_p.R206Q|ZNF28_ENST00000414252.2_Missense_Mutation_p.R153Q|ZNF28_ENST00000360272.4_Missense_Mutation_p.R153Q			P17035	ZNF28_HUMAN	zinc finger protein 28	206					regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			breast(2)|central_nervous_system(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(11)|liver(1)|lung(10)|skin(3)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(1)	34				GBM - Glioblastoma multiforme(134;0.0386)|Lung(386;0.145)		GTGTACATTCCGTTTTTGTGT	0.333																																														0								C	GLN/ARG	0,4406		0,0,2203	130	138	136		617.0	-3.3	0.0	19		136.0	1,8599		0,1,4299	no	missense	ZNF28	NM_006969.3	43.0	0,1,6502	TT,TC,CC		0.0116,0.0,0.0077	benign	206/719	53304481	1,13005	2203	4300	6503	SO:0001583	missense			ENSG00000198538	HGNC:13073	NM_006969	Approved	uc002qad.3	ENST00000438150.2:c.458G>A	19.37:g.53304481C>T	ENSP00000412143:p.Arg153Gln		A8KAK9|B4E3G0|B9EIK7|Q5H9V1|Q5HYM9|Q6ZML9|Q6ZN56	ENST00000438150.2	37		.	.	.	.	.	.	.	.	.	.	-	0.006	-2.082588	0.00371	0.0	1.16E-4	ENSG00000198538	ENST00000438150;ENST00000457749;ENST00000360272;ENST00000414252;ENST00000391783	T;T;T;T;T	0.26957	1.7;1.7;1.7;1.7;1.7	1.63	-3.27	0.05048	.	.	.	.	.	T	0.05640	0.0148	N	0.00960	-1.095	0.09310	N	1	B	0.02656	0.0	B	0.01281	0.0	T	0.28586	-1.0039	9	0.02654	T	1	.	6.2426	0.20800	0.0:0.3191:0.0:0.6809	.	206	P17035	ZNF28_HUMAN	Q	153;206;153;153;153	ENSP00000412143:R153Q;ENSP00000397693:R206Q;ENSP00000353410:R153Q;ENSP00000444965:R153Q;ENSP00000375661:R153Q	ENSP00000353410:R153Q	R	-	2	0	ZNF28	57996293	0.000000	0.05858	0.001000	0.08648	0.022000	0.10575	-1.657000	0.01979	-1.510000	0.01796	-1.202000	0.01658	CGG	ZNF28-004	PUTATIVE	alternative_5_UTR|basic	protein_coding		protein_coding	OTTHUMT00000396147.2	7.086409	KEEP		-	23.878115	0.109091	12	98					36.76	9	5	42	70	0.357143	0.0	0.0	1	0	0	29.76	0.642857	1	0.000151284	0.000214012	0.105934	0	41	8029	44	89	107	19	0	5	-2.644429	0.2159479	1	1	0	1	0
APOM	55937	broad.mit.edu	37	6	31625484	31625484	+	Silent	SNP	G	G	A			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr6:31625484G>A	ENST00000375916.3	+	5	1021	c.525G>A	c.(523-525)ttG>ttA	p.L175L	APOM_ENST00000375918.2_Silent_p.L103L|APOM_ENST00000375920.4_Silent_p.L103L	NM_019101.2	NP_061974.2	O95445	APOM_HUMAN	apolipoprotein M	175				LTPRNQEACELSNN -> VDS (in Ref. 2; CAB51604).	cholesterol efflux|high-density lipoprotein particle assembly|high-density lipoprotein particle clearance|high-density lipoprotein particle remodeling|negative regulation of plasma lipoprotein particle oxidation|reverse cholesterol transport	discoidal high-density lipoprotein particle|integral to plasma membrane|low-density lipoprotein particle|spherical high-density lipoprotein particle|very-low-density lipoprotein particle	binding|lipid transporter activity			breast(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(1)|lung(1)	7						CCTTCTTATTGACTCCTAGGA	0.488																																			Colon(39;129 858 13764 41453 42617)											0													131	136	134					6																	31625484		1511	2709	4220	SO:0001819	synonymous_variant			ENSG00000204444	HGNC:13916	NM_019101	Approved	uc003nvl.3	ENST00000375916.3:c.525G>A	6.37:g.31625484G>A			B0UX98|Q9P046|Q9UMP6	ENST00000375916.3	37	CCDS4710.1																																																																																			APOM-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000076527.3	18.687337	KEEP		+	29.12455	0.153846	14	77					36.76	10	9	46	50	0.526316	0.0	0.0	1	0	0	29.76	0.473684	1	6.94344e-10	1.91771e-09	0.175082	0	728	7471	75	37	23	0	0	0	-9.535446	0.9999459	1	1	1	1	0
APPL1	26060	broad.mit.edu	37	3	57301786	57301786	+	Missense_Mutation	SNP	G	G	T			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr3:57301786G>T	ENST00000288266.3	+	20	2006	c.1859G>T	c.(1858-1860)gGa>gTa	p.G620V		NM_012096.2	NP_036228.1	Q9UKG1	DP13A_HUMAN	adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1	620	PID.				apoptosis|cell cycle|cell proliferation|insulin receptor signaling pathway|regulation of apoptosis|regulation of establishment of protein localization in plasma membrane|regulation of glucose import	cytosol|early endosome membrane|microsome|nucleus|vesicle membrane	protein kinase B binding			breast(3)|endometrium(3)|kidney(3)|large_intestine(10)|liver(2)|lung(4)|prostate(2)	27				KIRC - Kidney renal clear cell carcinoma(284;0.0124)|Kidney(284;0.0144)		GATTCTGTTGGACTGGCAAAA	0.413																																														0													159	150	153					3																	57301786		2203	4300	6503	SO:0001583	missense			ENSG00000157500	HGNC:24035	NM_012096	Approved	uc003dio.3	ENST00000288266.3:c.1859G>T	3.37:g.57301786G>T	ENSP00000288266:p.Gly620Val		Q9P2B9	ENST00000288266.3	37	CCDS2882.1	.	.	.	.	.	.	.	.	.	.	G	24.1	4.497713	0.85069	.	.	ENSG00000157500	ENST00000288266	T	0.27720	1.65	5.78	5.78	0.91487	Phosphotyrosine interaction domain (2);Pleckstrin homology-type (1);	0.000000	0.85682	D	0.000000	T	0.54565	0.1866	L	0.60455	1.87	0.80722	D	1	D;D	0.76494	0.999;0.999	D;D	0.71414	0.973;0.973	T	0.53165	-0.8477	10	0.72032	D	0.01	-20.384	20.0044	0.97430	0.0:0.0:1.0:0.0	.	603;620	B4DQX8;Q9UKG1	.;DP13A_HUMAN	V	620	ENSP00000288266:G620V	ENSP00000288266:G620V	G	+	2	0	APPL1	57276826	1.000000	0.71417	1.000000	0.80357	0.996000	0.88848	8.333000	0.90026	2.714000	0.92807	0.650000	0.86243	GGA	APPL1-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000258196.2	-2.572611	KEEP		+	8.811442	0.079365	5	58					36.76	0	5	36	35	0.0	1.024e-07	1.16455e-07	1	1	0	29.76	1.0	0	0.0	0.0	0.184627	0	49	8050	198	33	0	0	0	0	-9.726177	0.9999961	1	1	1	1	0
DCC	1630	broad.mit.edu	37	18	50929242	50929242	+	Missense_Mutation	SNP	G	G	A			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr18:50929242G>A	ENST00000442544.2	+	19	3530	c.2914G>A	c.(2914-2916)Gaa>Aaa	p.E972K	DCC_ENST00000412726.1_Missense_Mutation_p.E800K|DCC_ENST00000581580.1_Missense_Mutation_p.E607K	NM_005215.3	NP_005206.2	P43146	DCC_HUMAN	deleted in colorectal carcinoma	972	Fibronectin type-III 6.				apoptosis|induction of apoptosis|negative regulation of collateral sprouting|negative regulation of dendrite development	cytosol|integral to membrane				NS(3)|breast(2)|central_nervous_system(1)|cervix(2)|endometrium(13)|haematopoietic_and_lymphoid_tissue(2)|kidney(5)|large_intestine(23)|liver(1)|lung(56)|ovary(7)|pancreas(3)|prostate(2)|skin(16)|stomach(2)|upper_aerodigestive_tract(4)|urinary_tract(6)	148		all_cancers(7;0.11)|all_epithelial(6;0.00126)		Colorectal(16;0.0251)|COAD - Colon adenocarcinoma(17;0.0942)		GCCTCCCTTGGAAGCCAATGG	0.532																																														0													173	152	159					18																	50929242		2203	4300	6503	SO:0001583	missense			ENSG00000187323	HGNC:2701	NM_005215	Approved	uc002lfe.2	ENST00000442544.2:c.2914G>A	18.37:g.50929242G>A	ENSP00000389140:p.Glu972Lys			ENST00000442544.2	37	CCDS11952.1	.	.	.	.	.	.	.	.	.	.	G	19.17	3.775896	0.70107	.	.	ENSG00000187323	ENST00000442544;ENST00000412726	T;T	0.57273	0.41;0.41	6.03	6.03	0.97812	Fibronectin, type III (4);Immunoglobulin-like fold (1);	0.000000	0.85682	D	0.000000	T	0.69151	0.3079	L	0.52126	1.63	0.80722	D	1	D;D;D	0.71674	0.964;0.964;0.998	P;P;D	0.72075	0.794;0.794;0.976	T	0.67749	-0.5590	10	0.59425	D	0.04	.	19.3283	0.94273	0.0:0.0:1.0:0.0	.	800;800;972	E7EQM8;B4DYX2;P43146	.;.;DCC_HUMAN	K	972;800	ENSP00000389140:E972K;ENSP00000397322:E800K	ENSP00000397322:E800K	E	+	1	0	DCC	49183240	1.000000	0.71417	1.000000	0.80357	0.999000	0.98932	9.683000	0.98657	2.861000	0.98227	0.655000	0.94253	GAA	DCC-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000255996.3	1.438543	KEEP		+	8.678229	0.106383	5	42					36.76	5	1	25	26	0.833333	0.0	0.0	1	0	0	29.76	0.166667	1	5.9392e-07	1.18784e-06	0.021553	0	46	8069	76	90	50	0	0	0	-4.739638	0.9909883	1	1	1	1	0
APPL1	26060	broad.mit.edu	37	3	57301785	57301785	+	Nonsense_Mutation	SNP	G	G	T			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr3:57301785G>T	ENST00000288266.3	+	20	2005	c.1858G>T	c.(1858-1860)Gga>Tga	p.G620*		NM_012096.2	NP_036228.1	Q9UKG1	DP13A_HUMAN	adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1	620	PID.				apoptosis|cell cycle|cell proliferation|insulin receptor signaling pathway|regulation of apoptosis|regulation of establishment of protein localization in plasma membrane|regulation of glucose import	cytosol|early endosome membrane|microsome|nucleus|vesicle membrane	protein kinase B binding			breast(3)|endometrium(3)|kidney(3)|large_intestine(10)|liver(2)|lung(4)|prostate(2)	27				KIRC - Kidney renal clear cell carcinoma(284;0.0124)|Kidney(284;0.0144)		TGATTCTGTTGGACTGGCAAA	0.413																																														0													159	150	153					3																	57301785		2203	4300	6503	SO:0001587	stop_gained			ENSG00000157500	HGNC:24035	NM_012096	Approved	uc003dio.3	ENST00000288266.3:c.1858G>T	3.37:g.57301785G>T	ENSP00000288266:p.Gly620*		Q9P2B9	ENST00000288266.3	37	CCDS2882.1	.	.	.	.	.	.	.	.	.	.	G	38	7.143601	0.98092	.	.	ENSG00000157500	ENST00000288266	.	.	.	5.78	5.78	0.91487	.	0.000000	0.85682	D	0.000000	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.72032	D	0.01	-20.384	20.0044	0.97430	0.0:0.0:1.0:0.0	.	.	.	.	X	620	.	ENSP00000288266:G620X	G	+	1	0	APPL1	57276825	1.000000	0.71417	1.000000	0.80357	0.996000	0.88848	8.333000	0.90026	2.714000	0.92807	0.650000	0.86243	GGA	APPL1-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000258196.2	-2.271643	KEEP		+	8.847435	0.080645	5	57					36.76	0	5	35	35	0.0	1.024e-07	1.16455e-07	1	1	0	29.76	1.0	0	0.0	0.0	0.184627	0	49	7949	238	73	10	15	0	0	-2.749849	0.9597597	1	1	1	1	0
WHSC1	7468	broad.mit.edu	37	4	1955156	1955156	+	Missense_Mutation	SNP	C	C	A			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr4:1955156C>A	ENST00000382895.3	+	14	2674	c.2243C>A	c.(2242-2244)cCt>cAt	p.P748H	WHSC1_ENST00000382888.3_Missense_Mutation_p.P96H|WHSC1_ENST00000508803.1_Missense_Mutation_p.P748H|WHSC1_ENST00000482415.2_3'UTR|WHSC1_ENST00000382892.2_Missense_Mutation_p.P748H|WHSC1_ENST00000382891.5_Missense_Mutation_p.P748H	NM_133330.2	NP_579877.1	O96028	NSD2_HUMAN	Wolf-Hirschhorn syndrome candidate 1	748					anatomical structure morphogenesis|regulation of transcription, DNA-dependent|transcription, DNA-dependent	chromosome|cytoplasm|nuclear membrane|nucleolus	DNA binding|histone-lysine N-methyltransferase activity|zinc ion binding			breast(1)|central_nervous_system(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(10)|lung(14)|ovary(4)|pancreas(1)|prostate(3)|skin(4)|urinary_tract(3)	48		all_epithelial(65;1.34e-05)	OV - Ovarian serous cystadenocarcinoma(23;0.00606)	STAD - Stomach adenocarcinoma(129;0.232)		AAAAAATACCCTCTGACTGTA	0.483			T	IGH@	MM																																Dom	yes		4.0	4p16.3	7468.0	Wolf-Hirschhorn syndrome candidate 1(MMSET)		L	0													163	174	170					4																	1955156		2203	4300	6503	SO:0001583	missense			ENSG00000109685	HGNC:12766	NM_133330	Approved	uc003gdz.4	ENST00000382895.3:c.2243C>A	4.37:g.1955156C>A	ENSP00000372351:p.Pro748His		A2A2T3|A2A2T4|A7MCZ1|D3DVQ2|O96031|Q4VBY8|Q672J1|Q6IS00|Q86V01|Q9BZB4|Q9UI92|Q9UPR2	ENST00000382895.3	37	CCDS33940.1	.	.	.	.	.	.	.	.	.	.	C	15.04	2.716403	0.48622	.	.	ENSG00000109685	ENST00000508803;ENST00000382891;ENST00000382892;ENST00000382895;ENST00000382888	D;D;D;D;D	0.95622	-3.76;-3.76;-3.76;-3.76;-3.76	5.67	4.74	0.60224	Zinc finger, RING-type (2);Zinc finger, PHD-type (1);	0.119302	0.37136	N	0.002239	D	0.92172	0.7518	L	0.39566	1.225	0.80722	D	1	B;B	0.15141	0.012;0.008	B;B	0.15870	0.014;0.009	D	0.88933	0.3374	10	0.51188	T	0.08	.	13.2959	0.60296	0.2385:0.7615:0.0:0.0	.	96;748	A2A2T2;O96028	.;NSD2_HUMAN	H	748;748;748;748;96	ENSP00000423972:P748H;ENSP00000372347:P748H;ENSP00000372348:P748H;ENSP00000372351:P748H;ENSP00000372344:P96H	ENSP00000372344:P96H	P	+	2	0	WHSC1	1924954	0.055000	0.20627	0.957000	0.39632	0.862000	0.49288	1.937000	0.40193	2.672000	0.90937	0.655000	0.94253	CCT	WHSC1-008	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000366269.2	-11.30132	KEEP		+	8.515982	0.053191	5	89					36.76	0	5	60	58	1.0	1.0	1.0	1	1	0	29.76	0.0	0	0.0	0.0	0.184627	0	44	8098	31	30	125	6	0	0	-2.77711	0.5488036	1	1	1	1	0
FBN2	2201	broad.mit.edu	37	5	127855028	127855028	+	Missense_Mutation	SNP	C	C	T			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr5:127855028C>T	ENST00000508053.1	-	11	1540	c.566G>A	c.(565-567)cGt>cAt	p.R189H	FBN2_ENST00000508989.1_Missense_Mutation_p.R156H|FBN2_ENST00000262464.4_Missense_Mutation_p.R189H			P35556	FBN2_HUMAN	fibrillin 2	189	EGF-like 3.				bone trabecula formation|negative regulation of transforming growth factor beta receptor signaling pathway by extracellular sequestering of TGFbeta|positive regulation of bone mineralization|positive regulation of osteoblast differentiation	microfibril	calcium ion binding|extracellular matrix structural constituent			NS(1)|autonomic_ganglia(1)|biliary_tract(1)|breast(1)|endometrium(15)|haematopoietic_and_lymphoid_tissue(4)|kidney(13)|large_intestine(37)|liver(1)|lung(89)|ovary(9)|pancreas(2)|prostate(6)|skin(10)|stomach(1)|upper_aerodigestive_tract(5)|urinary_tract(1)	197		all_cancers(142;0.0216)|Prostate(80;0.0551)	KIRC - Kidney renal clear cell carcinoma(527;0.0268)|Kidney(363;0.0488)	OV - Ovarian serous cystadenocarcinoma(64;0.0821)|Epithelial(69;0.146)		TCCGATGCAACGTCCACCATT	0.433																																														0													83	77	79					5																	127855028		2203	4300	6503	SO:0001583	missense				HGNC:3604	NM_001999	Approved	uc003kuu.3	ENST00000508053.1:c.566G>A	5.37:g.127855028C>T	ENSP00000424571:p.Arg189His		B4DU01|Q59ES6	ENST00000508053.1	37	CCDS34222.1	.	.	.	.	.	.	.	.	.	.	C	22.1	4.247783	0.80024	.	.	ENSG00000138829	ENST00000262464;ENST00000508053;ENST00000508989;ENST00000502468	D;D;D;T	0.91843	-2.92;-2.92;-2.92;0.12	5.17	5.17	0.71159	Epidermal growth factor-like (1);Epidermal growth factor-like, type 3 (1);	0.074264	0.56097	D	0.000038	D	0.90126	0.6915	M	0.66506	2.035	0.54753	D	0.999983	P;P;B;B	0.41450	0.75;0.597;0.072;0.027	B;B;B;B	0.32149	0.117;0.141;0.012;0.007	D	0.91088	0.4904	10	0.54805	T	0.06	.	18.8636	0.92282	0.0:1.0:0.0:0.0	.	156;189;156;189	P35556-2;E9PHW4;D6RJI3;P35556	.;.;.;FBN2_HUMAN	H	189;189;156;189	ENSP00000262464:R189H;ENSP00000424571:R189H;ENSP00000425596:R156H;ENSP00000424753:R189H	ENSP00000262464:R189H	R	-	2	0	FBN2	127882927	0.999000	0.42202	0.994000	0.49952	0.673000	0.39480	5.804000	0.69135	2.861000	0.98227	0.655000	0.94253	CGT	FBN2-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000371618.2	16.883021	KEEP		-	19.248059	0.228571	8	27					36.76	6	6	11	21	0.5	0.0	0.0	1	0	0	29.76	0.5	1	3.07112e-06	4.81418e-06	0.080935	0	49	8055	182	40	6	0	0	0	-9.194548	0.9999967	1	1	1	1	0
ZFP30	22835	broad.mit.edu	37	19	38126172	38126172	+	Nonsense_Mutation	SNP	G	G	A			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr19:38126172G>A	ENST00000351218.2	-	6	1827	c.1270C>T	c.(1270-1272)Cag>Tag	p.Q424*	ZFP30_ENST00000392144.1_Nonsense_Mutation_p.Q424*|ZFP30_ENST00000589018.1_Intron|ZFP30_ENST00000514101.2_Nonsense_Mutation_p.Q424*	NM_014898.2	NP_055713.1	Q9Y2G7	ZFP30_HUMAN	ZFP30 zinc finger protein	424					regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			autonomic_ganglia(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(12)|prostate(1)|soft_tissue(1)|upper_aerodigestive_tract(1)	21			COAD - Colon adenocarcinoma(19;0.114)|Colorectal(19;0.177)			TGAGTAAGCTGTGAGAACAGC	0.388																																														0													67	66	66					19																	38126172		2203	4300	6503	SO:0001587	stop_gained			ENSG00000120784	HGNC:29555	NM_014898	Approved	uc002ogx.1	ENST00000351218.2:c.1270C>T	19.37:g.38126172G>A	ENSP00000343581:p.Gln424*		Q58EY8	ENST00000351218.2	37	CCDS33005.1	.	.	.	.	.	.	.	.	.	.	G	37	6.223220	0.97390	.	.	ENSG00000120784	ENST00000351218;ENST00000514101;ENST00000392144;ENST00000440715	.	.	.	3.9	2.75	0.32379	.	0.000000	0.33419	N	0.004923	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.09843	T	0.71	.	10.7594	0.46256	0.0:0.0:0.7484:0.2516	.	.	.	.	X	424;424;424;339	.	ENSP00000343581:Q424X	Q	-	1	0	ZFP30	42818012	0.000000	0.05858	1.000000	0.80357	0.989000	0.77384	-1.668000	0.01959	2.175000	0.68902	0.591000	0.81541	CAG	ZFP30-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000109601.2	-0.436167	KEEP		-	7.773112	0.085106	4	43					36.76	1	3	24	27	0.25	0.0	0.0	1	0	0	29.76	0.75	1	0.150653	0.178324	0.150653	0	49	7987	265	29	0	0	0	0	-8.870593	0.9999811	1	1	1	1	0
UBA1	7317	broad.mit.edu	37	X	47072412	47072412	+	Missense_Mutation	SNP	C	C	G			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chrX:47072412C>G	ENST00000335972.6	+	23	2853	c.2670C>G	c.(2668-2670)atC>atG	p.I890M	UBA1_ENST00000377269.3_Missense_Mutation_p.I338M|UBA1_ENST00000377351.4_Missense_Mutation_p.I890M	NM_003334.3	NP_003325.2	P22314	UBA1_HUMAN	ubiquitin-like modifier activating enzyme 1	890					cell death|protein modification process		ATP binding|ligase activity|protein binding|small protein activating enzyme activity			breast(2)|cervix(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(5)|lung(7)|ovary(3)|upper_aerodigestive_tract(1)|urinary_tract(1)	31						CAGGGAAGATCATCCCAGCCA	0.542																																														0													92	72	79					X																	47072412		2203	4300	6503	SO:0001583	missense			ENSG00000130985	HGNC:12469	NM_003334	Approved	uc004dhj.4	ENST00000335972.6:c.2670C>G	X.37:g.47072412C>G	ENSP00000338413:p.Ile890Met		Q5JRR8|Q96E13	ENST00000335972.6	37	CCDS14275.1	.	.	.	.	.	.	.	.	.	.	C	18.01	3.527932	0.64860	.	.	ENSG00000130985	ENST00000377351;ENST00000335972;ENST00000377269	T;T;T	0.62364	0.03;0.03;0.03	5.34	3.57	0.40892	Molybdenum cofactor biosynthesis, MoeB (1);	0.052745	0.85682	D	0.000000	D	0.87330	0.6150	H	0.99884	4.89	0.54753	D	0.999981	D;D	0.89917	1.0;1.0	D;D	0.87578	0.998;0.995	D	0.86284	0.1669	10	0.87932	D	0	-23.9576	7.3894	0.26901	0.1662:0.7448:0.0:0.089	.	338;890	Q5JRR6;P22314	.;UBA1_HUMAN	M	890;890;338	ENSP00000366568:I890M;ENSP00000338413:I890M;ENSP00000366481:I338M	ENSP00000338413:I890M	I	+	3	3	UBA1	46957356	1.000000	0.71417	1.000000	0.80357	0.994000	0.84299	1.966000	0.40481	0.568000	0.29311	0.529000	0.55759	ATC	UBA1-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000056389.1	10.294879	KEEP		+	10.723645	0.307692	4	9					36.76	3	2	4	8	0.4	0.0	0.0	1	0	0	29.76	0.6	0	0.0	0.0	0.184627	0	51	8000	239	39	0	0	0	0	-11.64329	0.9999985	1	1	1	1	0
NFYC	4802	broad.mit.edu	37	1	41223958	41223958	+	Nonsense_Mutation	SNP	C	C	T			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr1:41223958C>T	ENST00000372652.1	+	6	821	c.553C>T	c.(553-555)Cag>Tag	p.Q185*	NFYC_ENST00000425457.2_Nonsense_Mutation_p.Q185*|NFYC_ENST00000308733.5_Nonsense_Mutation_p.Q185*|NFYC_ENST00000372654.1_Nonsense_Mutation_p.Q185*|NFYC_ENST00000447388.3_Nonsense_Mutation_p.Q185*|NFYC_ENST00000440226.3_Nonsense_Mutation_p.Q185*|NFYC_ENST00000456393.2_Nonsense_Mutation_p.Q185*|NFYC_ENST00000427410.2_Nonsense_Mutation_p.Q147*|NFYC_ENST00000372651.1_Nonsense_Mutation_p.Q185*|NFYC_ENST00000372653.1_Nonsense_Mutation_p.Q185*			Q13952	NFYC_HUMAN	nuclear transcription factor Y, gamma	185					protein folding|regulation of transcription from RNA polymerase II promoter	CCAAT-binding factor complex	protein binding|sequence-specific DNA binding|sequence-specific DNA binding transcription factor activity|transcription coactivator activity			NS(1)|breast(3)|endometrium(2)|kidney(2)|large_intestine(3)|lung(1)|prostate(1)|skin(2)	15	Ovarian(52;0.00769)|all_hematologic(146;0.0501)|Acute lymphoblastic leukemia(166;0.074)	Myeloproliferative disorder(586;0.0255)	OV - Ovarian serous cystadenocarcinoma(33;1.72e-17)			ACAGCCTCAGCAGGGCCAGGT	0.617																																														0													33	32	32					1																	41223958		2203	4300	6503	SO:0001587	stop_gained			ENSG00000066136	HGNC:7806	NM_014223	Approved	uc009vwd.3	ENST00000372652.1:c.553C>T	1.37:g.41223958C>T	ENSP00000361736:p.Gln185*		D3DPV9|Q5T6K8|Q5T6L1|Q5TZR6|Q92869|Q9HBX1|Q9NXB5|Q9UM67|Q9UML0|Q9UMT7	ENST00000372652.1	37		.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	36|36	5.768740|5.768740	0.96914|0.96914	.|.	.|.	ENSG00000066136|ENSG00000066136	ENST00000414185|ENST00000427410;ENST00000447388;ENST00000425457;ENST00000456393;ENST00000372658;ENST00000372655;ENST00000372654;ENST00000372653;ENST00000372669;ENST00000372652;ENST00000372651;ENST00000440226;ENST00000416859;ENST00000308733	.|.	.|.	.|.	5.7|5.7	5.7|5.7	0.88788|0.88788	.|.	.|0.000000	.|0.85682	.|D	.|0.000000	T|.	0.76891|.	0.4051|.	.|.	.|.	.|.	0.80722|0.80722	A|A	1|1	.|.	.|.	.|.	.|.	.|.	.|.	T|.	0.78650|.	-0.2121|.	3|.	.|0.62326	.|D	.|0.03	.|.	17.3316|17.3316	0.87265|0.87265	0.0:1.0:0.0:0.0|0.0:1.0:0.0:0.0	.|.	.|.	.|.	.|.	V|X	67|147;185;185;185;83;83;185;185;185;185;185;185;153;185	.|.	.|ENSP00000312617:Q185X	A|Q	+|+	2|1	0|0	NFYC|NFYC	40996545|40996545	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.998000|0.998000	0.95712|0.95712	7.439000|7.439000	0.80444|0.80444	2.711000|2.711000	0.92665|0.92665	0.561000|0.561000	0.74099|0.74099	GCA|CAG	NFYC-004	KNOWN	basic	protein_coding		protein_coding	OTTHUMT00000020799.1	8.189693	KEEP		+	9.468292	0.222222	4	14					36.76	0	4	9	8	1.0	0.0	0.0	1	0	0	29.76	0.0	1	2.56e-06	4.12444e-06	0.150653	0	73	8023	208	29	0	0	0	0	-11.01141	0.9999996	1	1	1	1	0
TYK2	7297	broad.mit.edu	37	19	10489040	10489040	+	Missense_Mutation	SNP	C	C	T			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr19:10489040C>T	ENST00000525621.1	-	3	524	c.43G>A	c.(43-45)Gtt>Att	p.V15I	TYK2_ENST00000524462.1_Intron|TYK2_ENST00000529370.1_Missense_Mutation_p.V15I|TYK2_ENST00000264818.6_Missense_Mutation_p.V15I	NM_003331.4	NP_003322.3	P29597	TYK2_HUMAN	tyrosine kinase 2	15					intracellular protein kinase cascade|regulation of type I interferon-mediated signaling pathway|type I interferon-mediated signaling pathway	cytoskeleton|cytosol|membrane|nucleus	ATP binding|growth hormone receptor binding|non-membrane spanning protein tyrosine kinase activity			breast(1)|central_nervous_system(1)|endometrium(12)|haematopoietic_and_lymphoid_tissue(11)|kidney(6)|large_intestine(3)|lung(19)|ovary(4)|prostate(3)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(2)	64			OV - Ovarian serous cystadenocarcinoma(20;1.77e-09)|Epithelial(33;3.92e-06)|all cancers(31;8.95e-06)			CCATCCCCAACGGGCTTACTG	0.657																																														0									ILE/VAL	1,4405		0,1,2202	36	38	37		43.0	-0.3	0.0	19		37.0	0,8598		0,0,4299	no	missense	TYK2	NM_003331.4	29.0	0,1,6501	TT,TC,CC		0.0,0.0227,0.0077	benign	15/1188	10489040	1,13003	2203	4299	6502	SO:0001583	missense			ENSG00000105397	HGNC:12440		Approved	uc002moc.4	ENST00000525621.1:c.43G>A	19.37:g.10489040C>T	ENSP00000431885:p.Val15Ile		Q6QB10|Q96CH0	ENST00000525621.1	37	CCDS12236.1	.	.	.	.	.	.	.	.	.	.	-	11.03	1.520313	0.27211	2.27E-4	0.0	ENSG00000105397	ENST00000525621;ENST00000264818;ENST00000529370;ENST00000531836;ENST00000530829	T;T;T;T;T	0.80994	-0.91;-0.91;-1.44;0.71;1.5	4.55	-0.313	0.12754	.	0.819956	0.10067	N	0.720162	T	0.53981	0.1830	N	0.08118	0	0.09310	N	1	B;B	0.31893	0.345;0.137	B;B	0.23716	0.048;0.024	T	0.43845	-0.9366	10	0.37606	T	0.19	-1.7092	1.7274	0.02925	0.1663:0.485:0.1614:0.1873	.	15;15	E9PPF2;P29597	.;TYK2_HUMAN	I	15	ENSP00000431885:V15I;ENSP00000264818:V15I;ENSP00000432728:V15I;ENSP00000436175:V15I;ENSP00000436826:V15I	ENSP00000264818:V15I	V	-	1	0	TYK2	10350040	0.000000	0.05858	0.000000	0.03702	0.003000	0.03518	-0.262000	0.08682	-0.117000	0.11872	-0.428000	0.05917	GTT	TYK2-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000389443.1	3.376935	KEEP		-	8.263882	0.117647	4	30					36.76	3	1	18	20	0.25	0.0	0.0	1	0	0	29.76	0.75	1	0.150653	0.178324	0.150653	0	764	7319	222	28	0	0	0	0	-9.59645	0.9999941	1	1	1	1	0
GAS2L2	246176	broad.mit.edu	37	17	34073211	34073211	+	Silent	SNP	G	G	A			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr17:34073211G>A	ENST00000254466.6	-	6	1332	c.1305C>T	c.(1303-1305)ccC>ccT	p.P435P	GAS2L2_ENST00000587565.1_Silent_p.P419P	NM_139285.3	NP_644814.1	Q8NHY3	GA2L2_HUMAN	growth arrest-specific 2 like 2	435					cell cycle arrest	cytoplasm|cytoskeleton				central_nervous_system(1)|endometrium(1)|large_intestine(7)|lung(14)|ovary(2)|pancreas(1)|prostate(2)|skin(3)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(1)	35		Ovarian(249;0.17)		UCEC - Uterine corpus endometrioid carcinoma (308;0.0182)		TTTGTGGGGTGGGGTTCCCGG	0.597																																														0													124	138	133					17																	34073211		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000132139	HGNC:24846	NM_139285	Approved	uc002hjv.2	ENST00000254466.6:c.1305C>T	17.37:g.34073211G>A			Q8NHY4	ENST00000254466.6	37	CCDS11298.1																																																																																			GAS2L2-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000256497.1	0.787721	KEEP		-	7.936142	0.093023	4	39					36.76	5	0	21	25	1.0	0.0	0.0	1	0	0	29.76	0.0	1	1.024e-07	2.1997e-07	0.184627	0	39	8064	82	61	79	8	0	0	-2.998836	0.8912091	1	1	1	1	0
SLC2A3	6515	broad.mit.edu	37	12	8074065	8074065	+	Missense_Mutation	SNP	C	C	A			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr12:8074065C>A	ENST00000075120.7	-	10	1675	c.1435G>T	c.(1435-1437)Ggc>Tgc	p.G479C		NM_006931.2	NP_008862.1	P11169	GTR3_HUMAN	solute carrier family 2 (facilitated glucose transporter), member 3	479					carbohydrate metabolic process|water-soluble vitamin metabolic process	integral to membrane|plasma membrane	D-glucose transmembrane transporter activity|dehydroascorbic acid transporter activity			central_nervous_system(1)|cervix(2)|endometrium(1)|kidney(3)|large_intestine(2)|lung(14)|ovary(3)|pancreas(1)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	30				Kidney(36;0.0866)		TCCATGACGCCGTCCTTTCCA	0.557																																			Colon(96;424 1461 14416 20933 23688)											0													298	292	294					12																	8074065		2203	4300	6503	SO:0001583	missense			ENSG00000059804	HGNC:11007	NM_006931	Approved	uc001qtr.3	ENST00000075120.7:c.1435G>T	12.37:g.8074065C>A	ENSP00000075120:p.Gly479Cys		B2R606|D3DUU6|Q6I9U2|Q9UG15	ENST00000075120.7	37	CCDS8586.1	.	.	.	.	.	.	.	.	.	.	C	3.749	-0.052008	0.07362	.	.	ENSG00000059804	ENST00000075120;ENST00000540978	D	0.83250	-1.7	3.72	-1.65	0.08291	.	1.577390	0.03687	N	0.246486	T	0.70806	0.3266	N	0.08118	0	0.09310	N	1	B	0.31241	0.315	B	0.39840	0.311	T	0.62770	-0.6784	10	0.56958	D	0.05	.	4.7351	0.12984	0.3964:0.314:0.2895:0.0	.	479	P11169	GTR3_HUMAN	C	479;405	ENSP00000075120:G479C	ENSP00000075120:G479C	G	-	1	0	SLC2A3	7965332	0.000000	0.05858	0.000000	0.03702	0.001000	0.01503	-0.451000	0.06795	-0.231000	0.09825	-0.500000	0.04577	GGC	SLC2A3-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000257914.1	6.254225	KEEP		-	15.061327	0.125	8	56					36.76	5	5	39	43	0.5	2.17888e-05	2.38443e-05	1	1	0	29.76	0.5	0	0.0	0.0	0.058154	0	46	8103	31	39	109	6	0	0	-3.175891	0.8978028	1	1	1	1	0
COL19A1	1310	broad.mit.edu	37	6	70745829	70745829	+	Missense_Mutation	SNP	C	C	T			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr6:70745829C>T	ENST00000322773.4	+	14	1270	c.1168C>T	c.(1168-1170)Cct>Tct	p.P390S		NM_001858.4	NP_001849.2	Q14993	COJA1_HUMAN	collagen, type XIX, alpha 1	390	Triple-helical region 2 (COL2).				cell differentiation|cell-cell adhesion|extracellular matrix organization|skeletal system development	collagen	extracellular matrix structural constituent|protein binding, bridging			breast(4)|central_nervous_system(3)|cervix(1)|endometrium(9)|haematopoietic_and_lymphoid_tissue(5)|kidney(4)|large_intestine(8)|lung(54)|ovary(3)|prostate(2)|skin(10)|upper_aerodigestive_tract(4)|urinary_tract(2)	109						ACCAGCCTTACCTGTAAGTAT	0.318																																														0													75	77	76					6																	70745829		2203	4300	6503	SO:0001583	missense			ENSG00000082293	HGNC:2196		Approved	uc003pfc.1	ENST00000322773.4:c.1168C>T	6.37:g.70745829C>T	ENSP00000316030:p.Pro390Ser		Q00559|Q05850|Q12885|Q13676|Q14DH1|Q5JUF0|Q5T424|Q9H572|Q9NPZ2|Q9NQP2	ENST00000322773.4	37	CCDS4970.1	.	.	.	.	.	.	.	.	.	.	C	3.369	-0.128838	0.06753	.	.	ENSG00000082293	ENST00000322773	D	0.96587	-4.06	5.74	3.38	0.38709	.	0.967892	0.08518	N	0.933925	D	0.90844	0.7124	M	0.64404	1.975	0.80722	D	1	B	0.02656	0.0	B	0.04013	0.001	D	0.84888	0.0835	10	0.36615	T	0.2	.	7.5461	0.27768	0.6483:0.2821:0.0696:0.0	.	390	Q14993	COJA1_HUMAN	S	390	ENSP00000316030:P390S	ENSP00000316030:P390S	P	+	1	0	COL19A1	70802550	0.981000	0.34729	0.997000	0.53966	0.105000	0.19272	1.433000	0.34947	0.459000	0.27016	-0.397000	0.06425	CCT	COL19A1-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000041127.1	10.2274	KEEP		+	13.801201	0.171429	6	29					36.76	3	4	17	22	0.571429	0.0	0.0	1	0	0	29.76	0.428571	1	8.12818e-05	0.000117859	0.02938	0	48	8119	131	35	0	0	0	0	-13.14788	1.0	1	1	1	1	0
GJD2	57369	broad.mit.edu	37	15	35045465	35045465	+	Silent	SNP	G	G	A			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr15:35045465G>A	ENST00000290374.4	-	2	656	c.180C>T	c.(178-180)ccC>ccT	p.P60P		NM_020660.2	NP_065711.1	Q9UKL4	CXD2_HUMAN	gap junction protein, delta 2, 36kDa	60					synaptic transmission	connexon complex|integral to membrane	gap junction channel activity			endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(1)|lung(10)|ovary(1)|pancreas(1)|urinary_tract(1)	19		all_lung(180;9.67e-07)		all cancers(64;2.75e-18)|GBM - Glioblastoma multiforme(113;1.9e-07)|BRCA - Breast invasive adenocarcinoma(123;0.0156)		GGTTACAGCCGGGCTGCAGGG	0.547																																														0													92	82	86					15																	35045465		2201	4298	6499	SO:0001819	synonymous_variant			ENSG00000159248	HGNC:19154		Approved	uc001zis.2	ENST00000290374.4:c.180C>T	15.37:g.35045465G>A			Q2M241|Q9P2R0	ENST00000290374.4	37	CCDS10040.1																																																																																			GJD2-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000251875.2	6.619896	KEEP		-	7.482448	0.230769	3	10					36.76	3	0	3	10	1.0	0.0	0.0	1	0	0	29.76	0.0	1	6.4e-05	9.51795e-05	0.115264	0	48	7612	549	98	0	24	0	0	-3.061825	0.9400646	1	1	1	1	0
GYPA	2993	broad.mit.edu	37	4	145035900	145035900	+	Missense_Mutation	SNP	T	T	A			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr4:145035900T>A	ENST00000360771.4	-	6	493	c.378A>T	c.(376-378)aaA>aaT	p.K126N	GYPA_ENST00000512064.1_Missense_Mutation_p.K113N|RP11-673E1.4_ENST00000506982.1_RNA|GYPB_ENST00000283126.7_Intron|GYPA_ENST00000504786.1_Missense_Mutation_p.K94N|GYPA_ENST00000512789.1_Missense_Mutation_p.K61N|GYPA_ENST00000503627.1_Missense_Mutation_p.K81N|GYPA_ENST00000324022.10_Missense_Mutation_p.K93N|GYPA_ENST00000535709.1_Missense_Mutation_p.K100N	NM_002099.6	NP_002090.4	P02724	GLPA_HUMAN	glycophorin A (MNS blood group)	126					interspecies interaction between organisms	membrane fraction	receptor activity			central_nervous_system(2)|endometrium(1)|large_intestine(2)|lung(4)|skin(1)	10	all_hematologic(180;0.15)					AGGGGAGAGGTTTTACATCAG	0.333																																														0													78	80	79					4																	145035900		2203	4300	6503	SO:0001583	missense			ENSG00000170180	HGNC:4702	NM_002099	Approved	uc003ijo.4	ENST00000360771.4:c.378A>T	4.37:g.145035900T>A	ENSP00000354003:p.Lys126Asn		A8K3E6|Q9BS51	ENST00000360771.4	37	CCDS34069.1	.	.	.	.	.	.	.	.	.	.	T	14.56	2.571243	0.45798	.	.	ENSG00000170180	ENST00000360771;ENST00000324022;ENST00000535709;ENST00000512064;ENST00000512789;ENST00000504786;ENST00000503627	T;T;T;T;T;T;T	0.17528	2.27;2.27;2.27;2.27;2.27;2.27;2.27	4.72	2.18	0.27775	.	0.792557	0.10673	N	0.647288	T	0.13970	0.0338	L	0.39898	1.24	0.09310	N	1	B;B;B;B;B	0.30211	0.273;0.174;0.273;0.08;0.273	B;B;B;B;B	0.28709	0.059;0.026;0.093;0.059;0.059	T	0.25467	-1.0131	10	0.66056	D	0.02	-6.5711	6.52	0.22269	0.0:0.1974:0.0:0.8026	.	93;61;113;94;126	B8Q185;Q13030;E9PD10;E7EQF3;P02724	.;.;.;.;GLPA_HUMAN	N	126;93;100;113;61;94;81	ENSP00000354003:K126N;ENSP00000324483:K93N;ENSP00000445398:K100N;ENSP00000426130:K113N;ENSP00000425193:K61N;ENSP00000425549:K94N;ENSP00000421243:K81N	ENSP00000324483:K93N	K	-	3	2	GYPA	145255350	0.000000	0.05858	0.000000	0.03702	0.010000	0.07245	0.188000	0.17018	0.368000	0.24481	-0.334000	0.08254	AAA	GYPA-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000364783.1	3.479688	KEEP		-	8.364061	0.117647	4	30					36.76	2	3	30	12	0.4	0.0	0.0	1	0	0	29.76		0	0.0	0.0	0.184627	0	54	7973	266	32	5	4	0	0	-3.38559	0.9996703	1	1	1	1	0
LAMA5	3911	broad.mit.edu	37	20	60893644	60893644	+	Missense_Mutation	SNP	G	G	C			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr20:60893644G>C	ENST00000252999.3	-	53	7171	c.7105C>G	c.(7105-7107)Caa>Gaa	p.Q2369E		NM_005560.3	NP_005551.3	O15230	LAMA5_HUMAN	laminin, alpha 5	2369	Domain II and I.				angiogenesis|cell proliferation|cell recognition|cytoskeleton organization|endothelial cell differentiation|focal adhesion assembly|integrin-mediated signaling pathway|regulation of cell adhesion|regulation of cell migration|regulation of embryonic development|substrate adhesion-dependent cell spreading	extracellular space|laminin-1 complex|laminin-10 complex|laminin-11 complex	integrin binding			breast(2)|central_nervous_system(3)|cervix(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(3)|kidney(7)|lung(40)|ovary(1)|pancreas(1)|prostate(3)|skin(6)|stomach(1)|upper_aerodigestive_tract(5)|urinary_tract(2)	81	Breast(26;1.57e-08)		BRCA - Breast invasive adenocarcinoma(19;4.36e-06)		Alteplase(DB00009)|Anistreplase(DB00029)|Reteplase(DB00015)|Tenecteplase(DB00031)	TCGCGGGTTTGTGTGGCCAGT	0.677																																														0													33	42	39					20																	60893644		2181	4274	6455	SO:0001583	missense			ENSG00000130702	HGNC:6485	NM_005560	Approved	uc002ycq.3	ENST00000252999.3:c.7105C>G	20.37:g.60893644G>C	ENSP00000252999:p.Gln2369Glu		Q8TDF8|Q8WZA7|Q9H1P1	ENST00000252999.3	37	CCDS33502.1	.	.	.	.	.	.	.	.	.	.	-	0.004	-2.298508	0.00243	.	.	ENSG00000130702	ENST00000252999	T	0.09538	2.97	3.88	0.268	0.15626	Laminin I (1);	1.084410	0.07089	U	0.838444	T	0.03871	0.0109	N	0.03608	-0.345	0.09310	N	1	B	0.02656	0.0	B	0.01281	0.0	T	0.38112	-0.9676	10	0.02654	T	1	.	7.597	0.28054	0.0:0.3617:0.4351:0.2033	.	2369	O15230	LAMA5_HUMAN	E	2369	ENSP00000252999:Q2369E	ENSP00000252999:Q2369E	Q	-	1	0	LAMA5	60327039	0.000000	0.05858	0.000000	0.03702	0.022000	0.10575	0.350000	0.20079	0.591000	0.29711	0.436000	0.28706	CAA	LAMA5-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000080014.2	22.056139	KEEP		-	24.833713	0.225	9	31					36.76	10	4	28	16	0.714286	0.0	0.0	1	0	0	29.76	0.285714	0	0.0	0.0	0.105934	0	816	7330	138	49	0	0	0	0	-18.43457	0.9999992	1	1	1	1	0
C20orf26	26074	broad.mit.edu	37	20	20079307	20079307	+	Silent	SNP	C	C	A			AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr20:20079307C>A	ENST00000245957.5	+	8	784	c.708C>A	c.(706-708)ggC>ggA	p.G236G	C20orf26_ENST00000389656.3_5'UTR|C20orf26_ENST00000377309.2_5'UTR|C20orf26_ENST00000377306.1_Silent_p.G236G|C20orf26_ENST00000451767.2_Silent_p.G236G	NM_015585.3	NP_056400.3	Q8NHU2	CT026_HUMAN	chromosome 20 open reading frame 26	236										NS(2)|breast(3)|central_nervous_system(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(4)|large_intestine(11)|lung(42)|ovary(3)|pancreas(1)|prostate(2)|skin(2)|upper_aerodigestive_tract(1)	77				READ - Rectum adenocarcinoma(2;0.171)		AGGTGGAAGGCACAGCTGTTG	0.458																																														0													189	166	174					20																	20079307		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000089101	HGNC:15872	NM_015585	Approved	uc002wru.3	ENST00000245957.5:c.708C>A	20.37:g.20079307C>A			A6NHA1|Q5JXV4|Q5TE18|Q8N5R9|Q96M59|Q9BQL2|Q9H127|Q9H128|Q9NQH4|Q9UFV8|Q9Y4V7	ENST00000245957.5	37	CCDS33447.1																																																																																			C20orf26-004	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000078228.3	-18.091445	KEEP		+	9.600847	0.047244	6	121					36.76	0	6	60	77	1.0	1.0	1.0	1	1	0	29.76	0.0	0	0.0	0.0	0.021553	0	45	8163	53	56	16	0	0	0	-3.755222	0.9998631	1	1	1	1	0
GYS2	2998	broad.mit.edu	37	12	21711194	21711194	+	Silent	SNP	G	G	A	rs144580757		AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P05-Tumor-SM-63B4R	AC-P05-Normal-SM-63B4S	g.chr12:21711194G>A	ENST00000261195.2	-	11	1616	c.1362C>T	c.(1360-1362)gaC>gaT	p.D454D		NM_021957.3	NP_068776.2	P54840	GYS2_HUMAN	glycogen synthase 2 (liver)	454					glucose metabolic process|glycogen biosynthetic process|response to glucose stimulus	cortical actin cytoskeleton|cytosol|ectoplasm|insoluble fraction|soluble fraction	glycogen (starch) synthase activity|protein homodimerization activity			NS(1)|breast(2)|endometrium(5)|kidney(1)|large_intestine(14)|lung(14)|prostate(6)|skin(3)|upper_aerodigestive_tract(1)|urinary_tract(1)	48						TGAGGATGGGGTCGGTGGAGT	0.438																																			Colon(149;9 1820 3690 10544 50424)											0								G		1,4405	2.1+/-5.4	0,1,2202	185	152	163		1362.0	-1.0	1.0	12	dbSNP_134	163.0	2,8598	2.2+/-6.3	0,2,4298	no	coding-synonymous	GYS2	NM_021957.3		0,3,6500	AA,AG,GG		0.0233,0.0227,0.0231		454/704	21711194	3,13003	2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000111713	HGNC:4707	NM_021957	Approved	uc001rfb.3	ENST00000261195.2:c.1362C>T	12.37:g.21711194G>A			A0AVD8	ENST00000261195.2	37	CCDS8690.1																																																																																			GYS2-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000402396.1	3.890469	KEEP		-	8.277898	0.125	4	28					36.76	1	4	13	27	0.2	0.0	0.0	1	0	0	29.76	0.8	1	0.184627	0.214168	0.184627	0	48	8090	145	43	5	0	0	0	-5.765499	0.9999963	1	1	1	1	0
